QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic Cancer

NCT03127124 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped This study was withdrawn due to no enrollment

Conditions

Pancreatic Adenocarcinoma Metastatic

Interventions

DRUG: NANT-008
DRUG: Fluorouracil Injectable Product
DRUG: Avastin Injectable Product
DRUG: Leucovorin Calcium Injection
DRUG: Eloxatin Injectable Product

Sponsor

NantPharma, LLC